Immunovant
IMVT
IMVT
112 hedge funds and large institutions have $197M invested in Immunovant in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 44 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
14% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 44
32% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 19
39% less capital invested
Capital invested by funds: $322M → $197M (-$124M)
Holders
112
Holding in Top 10
1
Calls
$6.87M
Puts
$532K
Top Buyers
| 1 | +$13.5M | |
| 2 | +$7.74M | |
| 3 | +$4.97M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.33M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.28M |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$9.72M | |
| 3 | -$4.99M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.43M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$1.76M |